ImmunityBio, Inc.
DE ˙ DB ˙ US45256X1037
6,13 € ↓ -0,20 (-3,16%)
2026-06-05
DEL PRIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionPnc Financial Services Group, Inc.
Latest Disclosed Ownership39,030 shares
Latest Disclosed Value $ 299,360
Pnc Financial Services Group, Inc. reports 11.20% increase in ownership of 26CA / ImmunityBio, Inc.

On May 8, 2026 - Pnc Financial Services Group, Inc. filed a 13F-HR form disclosing ownership of 39,030 shares of ImmunityBio, Inc. (DE:26CA) valued at $256,037 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 35,100 shares of ImmunityBio, Inc.. This represents a change in shares of 11.20% during the quarter. The current value of the position is $239,254 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F IMMUNITYBIO COM 45256X103 39,030 3,930 11.20 299 333.33 0.0000
2026-02-06 2025-12-31 13F IMMUNITYBIO COM 45256X103 35,100 -10,068 -22.29 69 -37.84 0.0000
2025-11-07 2025-09-30 13F IMMUNITYBIO COM 45256X103 45,168 31,353 226.95 111 208.33 0.0001
2025-08-08 2025-06-30 13F IMMUNITYBIO COM 45256X103 13,815 12,668 1,104.45 36 1,100.00 0.0000
2025-05-09 2025-03-31 13F IMMUNITYBIO COM 45256X103 1,147 1,113 3,273.53 3 0.0000
2025-02-07 2024-12-31 13F IMMUNITYBIO COM 45256X103 34 -2,000 -98.33 0 -100.00 0.0000
2024-11-08 2024-09-30 13F IMMUNITYBIO COM 45256X103 2,034 0 0.00 8 -41.67 0.0000
2024-08-09 2024-06-30 13F IMMUNITYBIO COM 45256X103 2,034 1,000 96.71 13 140.00 0.0000
2024-05-10 2024-03-31 13F IMMUNITYBIO COM 45256X103 1,034 -1,000 -49.16 6 -50.00 0.0000
2024-03-22 2023-12-31 13F/A-1 IMMUNITYBIO COM 45256X103 2,034 -7,966 -79.66 10 -37.50 0.0000
2024-02-09 2023-12-31 13F IMMUNITYBIO COM 45256X103 2,034 -7,966 10 0.0000
2023-11-13 2023-09-30 13F IMMUNITYBIO COM 45256X103 10,000 -10,100 -50.25 17 -70.91 0.0000
2023-08-11 2023-06-30 13F IMMUNITYBIO COM 45256X103 20,100 20,100 56 0.0000
2022-02-11 2021-12-31 13F IMMUNITYBIO COM 45256X103 0 -250 -100.00 0 -100.00
2021-11-05 2021-09-30 13F IMMUNITYBIO COM 45256X103 250 0 0.00 2 -50.00 0.0000
2021-08-06 2021-06-30 13F IMMUNITYBIO COM 45256X103 250 0 0.00 4 -33.33 0.0000
2021-05-07 2021-03-31 13F IMMUNITYBIO COM 45256X103 250 -250 -50.00 6 -14.29 0.0000
2021-02-12 2020-12-31 13F NANTKWEST COM 63016Q102 500 -650 -56.52 7 -12.50 0.0000
2020-11-06 2020-09-30 13F NANTKWEST COM 63016Q102 1,150 500 76.92 8 0.00 0.0000
2020-08-28 2020-06-30 13F/A-1 NANTKWEST COM 63016Q102 650 650 8 0.0000
2020-08-07 2020-06-30 13F NANTKWEST COM 63016Q102 650 650 8 1.6611
2019-08-09 2019-06-30 13F NANTKWEST COM 63016Q102 0 -500 -100.00 0 -100.00
2019-05-10 2019-03-31 13F NANTKWEST COM 63016Q102 500 0 0.00 1 0.00 0.0000
2019-02-08 2018-12-31 13F NANTKWEST COM 63016Q102 500 0 0.00 1 -50.00 0.0000
2018-11-09 2018-09-30 13F NANTKWEST COM 63016Q102 500 0 0.00 2 0.00 0.0000
2018-08-10 2018-06-30 13F NANTKWEST COM 63016Q102 500 0 0.00 2 0.00 0.0000
2018-05-11 2018-03-31 13F NANTKWEST COM 63016Q102 500 0 0.00 2 0.00 0.0000
2018-02-09 2017-12-31 13F NANTKWEST COM 63016Q102 500 0 0.00 2 -33.33 0.0000
2017-11-13 2017-09-30 13F NANTKWEST COM 63016Q102 500 0 0.00 3 -25.00 0.0000
2017-08-11 2017-06-30 13F NANTKWEST COM 63016Q102 500 0 0.00 4 100.00 0.0000
2017-05-12 2017-03-31 13F NANTKWEST COM 63016Q102 500 0 0.00 2 -33.33 0.0000
2017-02-10 2016-12-31 13F NANTKWEST COM 63016Q102 500 -1,000 -66.67 3 -75.00 0.0000
2016-11-04 2016-09-30 13F NANTKWEST COM 63016Q102 1,500 0 0.00 12 33.33 0.0000
2016-08-05 2016-06-30 13F NANTKWEST COM 63016Q102 1,500 0 0.00 9 -25.00 0.0000
2016-05-06 2016-03-31 13F NANTKWEST COM 63016Q102 1,500 0 0.00 12 -53.85 0.0000
2016-02-05 2015-12-31 13F NANTKWEST COM 63016Q102 1,500 -75 -4.76 26 44.44 0.0000
2015-11-06 2015-09-30 13F NANTKWEST Common Stock 63016Q102 1,575 1,575 18 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.